New donor cell therapy aims to prevent relapse in High-Risk blood cancer patients
NCT ID NCT07285668
First seen Jan 05, 2026 · Last updated May 22, 2026 · Updated 21 times
Summary
This study is for people with high-risk blood cancers who have already had a stem cell transplant from a donor. Researchers want to see if giving a special type of donor immune cell infusion, which has certain cells removed to lower side effects, is safe and can help prevent the cancer from coming back. The study involves up to 38 participants and will test different doses to find the safest one.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UW Carbone Cancer Center
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.